Stage IVA Squamous Cell Carcinoma of the Oropharynx Completed Phase 2 Trials for Patupilone (DB03010)

IndicationStatusPhase
DBCOND0029848 (Stage IVA Squamous Cell Carcinoma of the Oropharynx)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00033618Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and NeckTreatment